Glenmede Trust’s Innospec IOSP Stock Holding History

Glenmede Trust’s Portfolio IOSP Stock Details IOSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-694	Closed	-$43K	–	1717
2020 Q3	$43K	Buy	694 +46	+7%	+$3.42K	﹤0.01%	1371
2020 Q2	$49K	Buy	648 +127	+24%	+$9.29K	﹤0.01%	1318
2020 Q1	$53K	Hold	521	–	–	﹤0.01%	1668
2019 Q4	$53K	Buy	521 +83	+19%	+$7.94K	﹤0.01%	1668
2019 Q3	$38K	Buy	438 +25	+6%	+$2.24K	﹤0.01%	1782
2019 Q2	$37K	Hold	413	–	–	﹤0.01%	1823
2019 Q1	$33K	Buy	413 +105	+34%	+$7.83K	﹤0.01%	1879
2018 Q4	$18K	Buy	+308	New	+$21.2K	﹤0.01%	2043
2017 Q3	–	Sell	-8,528	Closed	-$552K	–	2775
2017 Q2	$552K	Hold	8,528	–	–	﹤0.01%	916
2017 Q1	$552K	Hold	8,528	–	–	﹤0.01%	916
2016 Q4	$584K	Hold	8,528	–	–	﹤0.01%	899
2016 Q3	$518K	Hold	8,528	–	–	﹤0.01%	922
2016 Q2	$392K	Buy	8,528 +2,425	+40%	+$115K	﹤0.01%	997
2016 Q1	$264K	Buy	6,103 +6,065	+15,961%	+$280K	﹤0.01%	1088
2015 Q4	$2K	Hold	38	–	–	﹤0.01%	2455
2015 Q3	$1K	Hold	38	–	–	﹤0.01%	2602
2015 Q2	$1K	Buy	+38	New	+$1.7K	﹤0.01%	2542
2013 Q3	–	Sell	-4,060	Closed	-$163K	–	2237
2013 Q2	$163K	Buy	+4,060	New	+$169K	﹤0.01%	1156

Other funds holding IOSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Glenmede Trust's IOSP Position: Q4 2020 in Review

Glenmede Trust sold out of Innospec (IOSP) in Q4 2020, closing a stake of 694 shares — an estimated $43K sold.

Glenmede Trust first reported a position in IOSP in Q2 2013 and held it in 18 quarters. The position peaked at $584K in Q4 2016. 180 funds tracked by Wall St. Rank hold IOSP as of Q4 2020.

Glenmede Trust reported no remaining Innospec position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 694 Innospec shares in Q4 2020, an estimated $43K.
Glenmede Trust first reported a position in Innospec in Q2 2013 and held it in 18 quarters.
Glenmede Trust's Innospec position peaked at $584K in Q4 2016.
180 funds tracked by Wall St. Rank held Innospec as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.